Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies. | Front Oncol;14: 1472463, 2024. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies.

de Lima, Marcos; Di Rocco, Alice; Ribera, Jose-Maria.

Affiliation

de Lima M; Department of Medicine, The Ohio State University, Columbus, OH, United States.
Di Rocco A; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Ribera JM; Department of Clinical Haematology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain.

Front Oncol ; 14: 1472463, 2024.

Article in En | MEDLINE | ID: mdl-39224808

Key words

chimeric antigen receptor (CAR T); leukemia; lymphoma; myeloma; toxicity

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2024 Document type: Article Affiliation country: United States Country of publication: Switzerland